Pre-order Enquiry
Request Free Sample
Global Opioids Drug Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024
SKU ID : GIR-13837456 | Publishing Date : 12-Feb-2019 | No. of pages : 119
Request Sample
Request Customization
Check Discounts
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
Scope of the Report:
The classification of Opioids Drug includes Oxycodone, Hydromorphone, Codeine, Fentanyl and Other, and the revenue proportion of Oxycodone in 2016 is about 33%, and the proportion is in decreasing trend from 2012 to 2016.
Opioids Drug is widely used for Pain Relief, Anesthesia and Other. The most proportion of Opioids Drug is for Pain Relief, and the proportion in 2016 is about 66.5%.
North America is the largest supplier of Opioids Drug, with a production market share nearly 71% in 2016. Europe is the second largest supplier of Opioids Drug Media, enjoying production market share nearly 16% in 2016.
North America is the largest consumption place, with a consumption market share nearly 60.5 % in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 20%.
Market competition is not intense. Purdue Pharma, J&J, Teva, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Opioids Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Opioids Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Purdue Pharma
J&J
Teva
Mylan
Depomed
INSYS
Endo
Pfizer
Hikma
Mallinckrodt
Pernix
Egalet
Vistapharm
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oxycodone
Hydromorphone
Codeine
Fentanyl
Other
Market Segment by Applications, can be divided into
Pain Relief
Anesthesia
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Opioids Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Opioids Drug, with price, sales, revenue and global market share of Opioids Drug in 2017 and 2018.
Chapter 3, the Opioids Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioids Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Opioids Drug market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Opioids Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Scope of the Report:
The classification of Opioids Drug includes Oxycodone, Hydromorphone, Codeine, Fentanyl and Other, and the revenue proportion of Oxycodone in 2016 is about 33%, and the proportion is in decreasing trend from 2012 to 2016.
Opioids Drug is widely used for Pain Relief, Anesthesia and Other. The most proportion of Opioids Drug is for Pain Relief, and the proportion in 2016 is about 66.5%.
North America is the largest supplier of Opioids Drug, with a production market share nearly 71% in 2016. Europe is the second largest supplier of Opioids Drug Media, enjoying production market share nearly 16% in 2016.
North America is the largest consumption place, with a consumption market share nearly 60.5 % in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 20%.
Market competition is not intense. Purdue Pharma, J&J, Teva, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
The worldwide market for Opioids Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Opioids Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Purdue Pharma
J&J
Teva
Mylan
Depomed
INSYS
Endo
Pfizer
Hikma
Mallinckrodt
Pernix
Egalet
Vistapharm
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oxycodone
Hydromorphone
Codeine
Fentanyl
Other
Market Segment by Applications, can be divided into
Pain Relief
Anesthesia
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Opioids Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Opioids Drug, with price, sales, revenue and global market share of Opioids Drug in 2017 and 2018.
Chapter 3, the Opioids Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Opioids Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Opioids Drug market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Opioids Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
